MedPath

UNDA 18

UNDA 18

Discontinued
DIN Number

02233233

Drug Class

Human

Market Date

Apr 6, 1998

Company
HC

seroyal international inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02233233
AIG Number0832402001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Homeopathic
Product Specifications
Dosage FormLiquid ,  Pellet ,  Granules ,  Drops ,  Tablet
Route of AdministrationOral
AHFS Classification92:02.00*
Health Canada Classification

ACTIVE INGREDIENTS (8)

ALUMINUMActive
Strength: 12 X
Monograph: ALUMINUM
ANTIMONY TRISULFIDEActive
Strength: 12 X
Monograph: ANTIMONY TRISULFIDE
CAMPHORActive
Strength: 9 X
Monograph: CAMPHOR
CONDURANGOActive
Strength: 5 X
Monograph: CONDURANGO
COPPERActive
Strength: 12 X
Monograph: COPPER
LYCOPODIUM CLAVATUMActive
Strength: 5 X
Monograph: LYCOPODIUM CLAVATUM
THUJA OCCIDENTALISActive
Strength: 5 X
Monograph: THUJA OCCIDENTALIS
VIBURNUM PRUNIFOLIUMActive
Strength: 5 X
Monograph: VIBURNUM PRUNIFOLIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.